SRXN1 and malignant colon neoplasm: For the evaluation of Srx function in colon CSCs, we first constructed an Srx-depleted HT29 (HT29-SrxKO) colon cancer line using the CRISPR/Cas9 system (Supplementary Fig. S4A).